Last update 23 Jan 2025

Ayerst-Wyeth Pharmaceuticals, Inc.

Subsidiary Company|
Puerto Rico

Overview

Tags

Other Diseases
Skin and Musculoskeletal Diseases
Neoplasms
Small molecule drug
Molecular glue

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Neoplasms2
Endocrinology and Metabolic Disease2
Infectious Diseases2
Immune System Diseases1
Nervous System Diseases1
Hemic and Lymphatic Diseases1
Top 5 Drug TypeCount
Small molecule drug2
Molecular glue1
Top 5 TargetCount
mTOR(Serine/threonine-protein kinase mTOR)1
30S subunit x Mitochondrial proteins1
ER(Estrogen receptors)1

Related

31
Drugs associated with Ayerst-Wyeth Pharmaceuticals, Inc.
Tigecycline
Target
30S subunit x Mitochondrial proteins
Mechanism
30S subunit inhibitors [+1]
Active Org.
Pfizer Europe MA EEIG [+7]
Originator Org.
Pfizer Inc.Pfizer Inc.
Active Indication
Abdominal Abscess [+12]
Inactive Indication
Community-Acquired Infections [+10]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
US
First Approval Date15 Jun 2005
Sirolimus
Target
mTOR
Mechanism
mTOR inhibitors
Active Org.
Santen Pharmaceutical Co., Ltd.Santen Pharmaceutical Co., Ltd. [+27]
Originator Org.
Pfizer Inc.Pfizer Inc.
Active Indication
Vascular Malformations [+82]
Inactive Indication
Acute Erythroblastic Leukemia [+120]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
US
First Approval Date15 Sep 1999
Estrogens, Conjugated
Target
ER
Mechanism
ERs agonists
Active Org.
Wyeth Pharmaceuticals LLC [+4]
Originator Org.
Ayerst-Wyeth Pharmaceuticals, Inc.
Active Indication
Oestrogen deficiency [+17]
Inactive Indication
Amenorrhea [+4]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
US
First Approval Date07 May 1942
1
Clinical Trials associated with Ayerst-Wyeth Pharmaceuticals, Inc.
NCT00681213
/ CompletedPhase 4IIT
Tacrolimus and Mycophenolate Versus Tacrolimus and Sirolimus vs. Neoral and Sirolimus Used in Combination in Cadaver and Non-HLA Identical Living Related Kidney Transplants
100 Clinical Results associated with Ayerst-Wyeth Pharmaceuticals, Inc.
Login to view more data
0 Patents (Medical) associated with Ayerst-Wyeth Pharmaceuticals, Inc.
Login to view more data
100 Deals associated with Ayerst-Wyeth Pharmaceuticals, Inc.
Login to view more data
100 Translational Medicine associated with Ayerst-Wyeth Pharmaceuticals, Inc.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 23 Feb 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Approved
3
28
Other
Login to view more data

Current Projects

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free